Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Renal hypoplasia, Focal impaired awareness seizure, Chordee, and Single transverse palmar crease and others; and common findings: Short stature, Low muscle tone (hypotonia), Thin corpus callosum, and Feeding difficulties and others. 100 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Focal impaired awareness seizure, Seizure, Dysarthria |
Eyes | 6 | Strabismus, Optic nerve hypoplasia, Damage to the optic nerve (optic atrophy) |
Head and neck | 6 | Cleft lip, Microcephaly, Triangular face |
Growth and development | 4 | Short stature, Tall stature, Intrauterine growth retardation |
Kidneys and urinary system | 3 | Renal hypoplasia, Renal cyst, Abnormality of the genitourinary system |
Digestive system | 3 | Gastroesophageal reflux, Feeding difficulties, Difficulty swallowing (dysphagia) |
Muscles | 2 | Low muscle tone (hypotonia), Damage to the optic nerve (optic atrophy) |
Bones and joints | 2 | Excessive inward curve of the lower back (lumbar hyperlordosis), Sideways curvature of the spine (scoliosis) |
Ears | 2 | Inner ear hearing loss (sensorineural hearing impairment), Hearing loss (hearing impairment) |
Arms and legs | 2 | Clinodactyly of the 5th finger, 3-4 finger osseus syndactyly |
Heart and blood vessels | 2 | Ventricular septal defect, Abnormal heart morphology |
Lungs and breathing | 2 | Anomalous pulmonary venous return, Sleep apnea |
Skin | 1 | Small nail |
RERE-related disorders are characterized by neurodevelopmental problems with or without structural anomalies of the eyes, heart, kidneys, and genitourinary tract and sensorineural hearing loss. To date, 19 individuals have been identified with a pathogenic variant in RERE . The following description of the phenotypic features associated with this condition is based on these reported cases. Developmental delay (DD) and intellectual disability (ID) have been documented in most individuals with RERE-related disorders and can vary from mild to profound. Some affected individuals may have normal early developmental milestones.
Source: GeneReviews — "RERE-Related Disorders"
RERE function has not been fully characterized.
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart is associated with mutations in the RERE gene on chromosome 1.
In general, pathogenic missense variants affecting the atrophin-1 domain of RERE are associated with an increased risk of structural eye defects, congenital heart defects, genitourinary anomalies, and sensorineural hearing loss when compared with loss-of-function variants . This suggests that some changes in this domain may represent dominant negative alleles. The , p.(Leu1438_His1439dup) variant is associated with a unique phenotypic presentation that includes many features commonly seen in individuals with CHARGE syndrome including coloboma, choanal atresia, congenital heart defects, growth deficiency, genitourinary anomalies, and DD/ID.
Source: GeneReviews — "RERE-Related Disorders"
No clinical diagnostic criteria have been published.
RERE-related disorders should be considered in individuals presenting with the following clinical and brain MRI findings. Clinical findings. Mild-to-profound developmental delay, intellectual disability, and/or autism spectrum disorder; AND any of the following features presenting in infancy or childhood:
Source: GeneReviews — "RERE-Related Disorders"
Because the phenotypic features associated with RERE-related disorders are not sufficient to diagnose this condition, all disorders with intellectual disability without other distinctive findings should be considered in the differential diagnosis. See OMIM Autosomal Dominant, Autosomal Recessive, Nonsyndromic X-Linked, and Syndromic X-Linked Intellectual Developmental Disorder Phenotypic Series.
Table 2.
Disorders to Consider in the Differential Diagnosis of RERE-Related Disorders
Disorder | Gene / Genetic Mechanism | MOI | Clinical Features of Differential Diagnosis Disorder
Overlapping w/RERE-related disorders | Distinguishing from RERE-related disorders
| CHD7 | AD | • Colobomata, congenital heart defects, choanal atresia, ear anomalies, genitourinary anomalies
Source: GeneReviews — "RERE-Related Disorders"
Genetic testing for RERE is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for neurodevelopmental disorder with or without anomalies of the brain, eye, or heart has been reported in the published literature.
No approved treatments are currently available for neurodevelopmental disorder with or without anomalies of the brain, eye, or heart. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with RERE-related disorders, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 3. Recommended Evaluations Following Initial Diagnosis in Individuals with RERE-Related Disorders
System/Concern | Evaluation | Comment |
|---|---|---|
Neurologic | Neurologic eval | May incl EEG brain MRI, as clinically indicated Psychiatric/ |
Behavioral | Neuropsychiatric eval | Screen individuals age 12 mos for behavior concerns incl sleep disturbances, ADHD, anxiety, /or traits suggestive of ASD. Developmental assessment |
Eyes | Ophthalmologic eval | To assess for structural eye anomalies vision problems |
Hearing | Audiologic eval | To assess for sensorineural hearing loss |
Cardiovascular | Echocardiogram | For eval of congenital heart defects Gastrointestinal/ |
Source: GeneReviews — "RERE-Related Disorders"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "RERE-Related Disorders"
View trials for neurodevelopmental disorder with or without anomalies of the brain, eye, or heart
Table 5. Recommended Surveillance for Individuals with RERE-Related Disorders
System/Concern | Evaluation | Frequency |
|---|---|---|
Neurodevelopment | Monitor developmental progress educational needs. | At least annually |
Neurologic | Monitor those w/seizures as clinically indicated. | As needed Psychiatric |
Eyes | Ophthalmologic eval | Annually or as clinically indicated Hearing |
Cardiovascular | Routine follow up w/cardiologist | As indicated for individuals w/congenital heart defects |
Genitourinary | Routine follow up w/urologist | As clinically indicated for those w/genitourinary issues |
Musculoskeletal | Clinical assessment for scoliosis | At least annually, until growth is complete |
Source: GeneReviews — "RERE-Related Disorders"
Phenotype severity distribution: 7 always present features, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for neurodevelopmental disorder with or without anomalies of the brain, eye, or heart.
249 publications have been identified in PubMed for neurodevelopmental disorder with or without anomalies of the brain, eye, or heart. Research spans Review / Meta-Analysis (26%), Basic Science / Preclinical (25%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 64 | 26% |
Laboratory research | 63 | 25% |
Patient case studies | 45 | 18% |
Disease patterns and progression | 38 | 15% |
New treatment approaches | 35 | 14% |
Testing and diagnosis research | 3 | 1% |
Clinical study results | 1 | 0% |
Dai Y (2026). [PMID: 41664155](https://pubmed.ncbi.nlm.nih.gov/41664155/). *Int J Dev Neurosci*. [Gene Therapy / Novel Therapeutics]
Natividad Avila M (2026). [PMID: 41912808](https://pubmed.ncbi.nlm.nih.gov/41912808/). *Nat Med*. [Epidemiology / Natural History]
Sugiyama R (2026). [PMID: 41147801](https://pubmed.ncbi.nlm.nih.gov/41147801/). *Clin Genet*. [Case Report / Case Series]
AlAbdi L (2026). [PMID: 41887223](https://pubmed.ncbi.nlm.nih.gov/41887223/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Galassi Deforie V (2026). [PMID: 41860019](https://pubmed.ncbi.nlm.nih.gov/41860019/). *Genet Med*. [Gene Therapy / Novel Therapeutics]
Livio Francisco S C (2026). [PMID: 41022135](https://pubmed.ncbi.nlm.nih.gov/41022135/). *J Pediatr (Rio J)*. [Review / Meta-Analysis]
Xu X (2026). [PMID: 42138082](https://pubmed.ncbi.nlm.nih.gov/42138082/). *J Clin Invest*. [Basic Science / Preclinical]
Savasta S (2026). [PMID: 42111496](https://pubmed.ncbi.nlm.nih.gov/42111496/). *Hum Mutat*. [Review / Meta-Analysis]
Bereshneh AH (2026). [PMID: 41556274](https://pubmed.ncbi.nlm.nih.gov/41556274/). *Genet Med*. [Case Report / Case Series]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 11:35 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Feeding
Assessment for signs symptoms of GERD |
Clinical assessment for sucking/swallowing difficulties |
Genitourinary | Renal ultrasound | There should be a high index of suspicion for vesicoureteral reflux, which is best evaluated using a VCUG. Assessment for cryptorchidism hypospadias in males |
Musculoskeletal | Clinical eval for congenital hip dysplasia in infants | Consider a hip ultrasound referral to orthopedist. Physical exam for signs of scoliosis |
Other | Consultation w/clinical geneticist /or genetic counselor | ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; EEG = electroencephalogram; GERD = gastroesophageal reflux disease; MRI = magnetic resonance imaging; VCUG = voiding cystourethrogram Treatment of Manifestations Table 4. |
Treatment of Manifestations in Individuals with RERE-Related Disorders Manifestation/Concern | Treatment | Considerations/Other |
Seizures1 | Standard treatment w/ASMs by experienced neurologist | Many different ASMs may be effective; none has been demonstrated effective specifically for this disorder. |
Abnormal vision /or strabismus | Standard treatment(s) as recommended by ophthalmologist | — |
Hearing loss | Standard therapy, which may incl hearing aids | See Hereditary Hearing Loss and Deafness Overview. |
Congenital heart defects | Standard treatment(s) as recommended by cardiologist | — |
Gastroesophageal reflux | Standard treatment(s) | — |
Feeding difficulties | Consider feeding therapy /or use of thickened liquids. | Eval by gastroenterologist /or feeding specialist Nasogastric or gastrostomy tube may be required if feeding difficulties fail to resolve. |
Genitourinary anomalies vesicoureteral reflux | Standard treatment(s) as recommended by urologist | — |
Scoliosis congenital hip dysplasia | Standard treatment(s) as recommended by orthopedist | ASM = anti-seizure medication Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see Epilepsy Foundation Toolbox. |